Clinical Trial

ED50 of Sufentanil for Intraoperative Analgesia

Study acronym: ED50
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 29, 2024 (before its estimated January 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
1. Sufentanil as an strong analgesic is used widespreadly during laparoscopic cholecystectomy. 2. Lower dosages of sufentanil facilitated with dexmedetomidine can offer enough analgesia effect. 3. The investigator are planning use the most classical method for determining the ED50 or half effective concentration of sufentanil facilitated with dexmedetomidine using sequential method, which is also called" up and down method" and" ladder method".
Trial Details
NCT Number NCT06662656
Lead Sponsor China International Neuroscience Institution
Conditions Laparoscopic Cholecystectomy, Analgesics，Opioid
Enrollment 26 participants
Start Date 2024-11-01
Primary Completion 2025-01-30 (estimated)
Study Completion 2025-01-30 (estimated)
Updated on ClinicalTrials.gov 2024-10-29